These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36305176)

  • 1. Role of skin autofluorescence in managing renal and cardiac diseases in outpatient dermatology.
    Etaee F; Naguib T; Goldust M; Daveluy S; Maibach H
    Skin Res Technol; 2022 Nov; 28(6):889-905. PubMed ID: 36305176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study.
    Viramontes Hörner D; Selby NM; Taal MW
    J Hum Nutr Diet; 2020 Dec; 33(6):852-861. PubMed ID: 32383489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
    PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.
    Majchrzak C; Cougnard-Gregoire A; Le-Goff M; Féart C; Delcourt C; Reydit M; Helmer C; Rigalleau V
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2526-2533. PubMed ID: 36064683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study.
    Chen J; Arshi B; Waqas K; Lu T; Bos D; Ikram MA; Uitterlinden AG; Kavousi M; Zillikens MC
    Cardiovasc Diabetol; 2023 Nov; 22(1):326. PubMed ID: 38017418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue advanced glycation end product deposition after kidney transplantation.
    Crowley LE; Johnson CP; McIntyre N; Fluck RJ; McIntyre CW; Taal MW; Leung JC
    Nephron Clin Pract; 2013; 124(1-2):54-9. PubMed ID: 24135496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.
    Shardlow A; McIntyre NJ; Kolhe NV; Nellums LB; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2020 Jul; 17(7):e1003163. PubMed ID: 32658890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease.
    Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D
    Pediatr Nephrol; 2015 May; 30(5):811-9. PubMed ID: 25409659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease.
    Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D
    Pediatr Nephrol; 2013 Jan; 28(1):121-8. PubMed ID: 22976887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence: an emerging biomarker in persons with kidney disease.
    Viramontes Hörner D; Taal MW
    Curr Opin Nephrol Hypertens; 2019 Nov; 28(6):507-512. PubMed ID: 31589190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
    Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis.
    Viramontes Hörner D; Selby NM; Taal MW
    J Ren Nutr; 2019 Mar; 29(2):149-155. PubMed ID: 30309781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.
    França RA; Esteves ABA; Borges CM; Quadros KRDS; Falcão LCN; Caramori JCT; Oliveira RB
    J Bras Nefrol; 2017; 39(3):253-260. PubMed ID: 28902232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation.
    Kunimoto M; Yokoyama M; Shimada K; Matsubara T; Aikawa T; Ouchi S; Fukao K; Miyazaki T; Fujiwara K; Abulimiti A; Honzawa A; Shimada A; Yamamoto T; Amano A; Saitoh M; Morisawa T; Takahashi T; Daida H; Minamino T
    Cardiovasc Diabetol; 2021 Oct; 20(1):208. PubMed ID: 34656131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the measurement of tissue advanced glycosylation products by skin autofluorescence associated with mortality in patients treated by peritoneal dialysis?
    Vareesangthip K; Fan S; Davenport A
    J Nephrol; 2023 Jan; 36(1):217-224. PubMed ID: 35980536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.
    McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2356-63. PubMed ID: 21885790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vegetarian diet on skin autofluorescence measurements in haemodialysis patients.
    Nongnuch A; Davenport A
    Br J Nutr; 2015 Apr; 113(7):1040-3. PubMed ID: 25761438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.